BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26494939)

  • 1. Bone Marrow Stromal Antigen 2 Is a Novel Plasma Biomarker and Prognosticator for Colorectal Carcinoma: A Secretome-Based Verification Study.
    Chiang SF; Kan CY; Hsiao YC; Tang R; Hsieh LL; Chiang JM; Tsai WS; Yeh CY; Hsieh PS; Liang Y; Chen JS; Yu JS
    Dis Markers; 2015; 2015():874054. PubMed ID: 26494939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Transmembrane Protein BST2 is Associated with Poor Survival of Patients with Esophageal, Gastric, or Colorectal Cancer.
    Mukai S; Oue N; Oshima T; Mukai R; Tatsumoto Y; Sakamoto N; Sentani K; Tanabe K; Egi H; Hinoi T; Ohdan H; Yasui W
    Ann Surg Oncol; 2017 Feb; 24(2):594-602. PubMed ID: 26832883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic large-scale meta-analysis identifies a panel of two mRNAs as blood biomarkers for colorectal cancer detection.
    Rodia MT; Ugolini G; Mattei G; Montroni I; Zattoni D; Ghignone F; Veronese G; Marisi G; Lauriola M; Strippoli P; Solmi R
    Oncotarget; 2016 May; 7(21):30295-306. PubMed ID: 26993598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BST2 induced macrophage M2 polarization to promote the progression of colorectal cancer.
    He X; Chen H; Zhong X; Wang Y; Hu Z; Huang H; Zhao S; Wei P; Shi D; Li D
    Int J Biol Sci; 2023; 19(1):331-345. PubMed ID: 36594082
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma membrane proteomics identifies bone marrow stromal antigen 2 as a potential therapeutic target in endometrial cancer.
    Yokoyama T; Enomoto T; Serada S; Morimoto A; Matsuzaki S; Ueda Y; Yoshino K; Fujita M; Kyo S; Iwahori K; Fujimoto M; Kimura T; Naka T
    Int J Cancer; 2013 Jan; 132(2):472-84. PubMed ID: 22729361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis.
    Cai D; Cao J; Li Z; Zheng X; Yao Y; Li W; Yuan Z
    BMC Cancer; 2009 Apr; 9():102. PubMed ID: 19338666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LGALS4, CEACAM6, TSPAN8, and COL1A2: Blood Markers for Colorectal Cancer-Validation in a Cohort of Subjects With Positive Fecal Immunochemical Test Result.
    Rodia MT; Solmi R; Pasini F; Nardi E; Mattei G; Ugolini G; Ricciardiello L; Strippoli P; Miglio R; Lauriola M
    Clin Colorectal Cancer; 2018 Jun; 17(2):e217-e228. PubMed ID: 29352642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating levels of periostin may help identify patients with more aggressive colorectal cancer.
    Ben QW; Zhao Z; Ge SF; Zhou J; Yuan F; Yuan YZ
    Int J Oncol; 2009 Mar; 34(3):821-8. PubMed ID: 19212687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of mannose receptor and CD163 as novel biomarkers for colorectal cancer.
    Ding D; Yao Y; Yang C; Zhang S
    Cancer Biomark; 2018 Feb; 21(3):689-700. PubMed ID: 29226859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of carcinoembryonic antigen (CEA), epidermal growth factor receptor (EGFR), epithelial cell adhesion molecule EpCAM (GA733-2), and carbohydrate antigen 19-9 (CA 19-9) levels in colorectal cancer patients and correlation with clinicopathological characteristics.
    Mourtzikou A; Stamouli M; Kroupis C; Christodoulou S; Skondra M; Kastania A; Pectasides D; Athanasas G; Dimas C
    Clin Lab; 2012; 58(5-6):441-8. PubMed ID: 22783573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD66c is a novel marker for colorectal cancer stem cell isolation, and its silencing halts tumor growth in vivo.
    Gemei M; Mirabelli P; Di Noto R; Corbo C; Iaccarino A; Zamboli A; Troncone G; Galizia G; Lieto E; Del Vecchio L; Salvatore F
    Cancer; 2013 Feb; 119(4):729-38. PubMed ID: 23027178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined identification of long non-coding RNA CCAT1 and HOTAIR in serum as an effective screening for colorectal carcinoma.
    Zhao W; Song M; Zhang J; Kuerban M; Wang H
    Int J Clin Exp Pathol; 2015; 8(11):14131-40. PubMed ID: 26823726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients.
    Zhang Q; Wang XQ; Wang J; Cui SJ; Lou XM; Yan B; Qiao J; Jiang YH; Zhang LJ; Yang PY; Liu F
    Oncotarget; 2015 Jun; 6(17):15095-110. PubMed ID: 25945835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endosialin (TEM1) as a Diagnostic, Progression, and Prognostic Serum Marker for Patients With Colorectal Cancer-A Preliminary Study.
    Pietrzyk Ł; Wdowiak P
    Cancer Control; 2020; 27(1):1073274820903351. PubMed ID: 32107922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokeratin serum biomarkers in patients with colorectal cancer.
    Holdenrieder S; Stieber P; Liska V; Treska V; Topolcan O; Dreslerova J; Matejka VM; Finek J; Holubec L
    Anticancer Res; 2012 May; 32(5):1971-6. PubMed ID: 22593474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
    Zhang SY; Lin M; Zhang HB
    Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetraspanin 6 is a regulator of carcinogenesis in colorectal cancer.
    Andrijes R; Hejmadi RK; Pugh M; Rajesh S; Novitskaya V; Ibrahim M; Overduin M; Tselepis C; Middleton GW; Győrffy B; Beggs AD; Berditchevski F
    Proc Natl Acad Sci U S A; 2021 Sep; 118(39):. PubMed ID: 34521767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial but not stromal expression of collagen alpha-1(III) is a diagnostic and prognostic indicator of colorectal carcinoma.
    Wang XQ; Tang ZX; Yu D; Cui SJ; Jiang YH; Zhang Q; Wang J; Yang PY; Liu F
    Oncotarget; 2016 Feb; 7(8):8823-38. PubMed ID: 26741506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptome analysis of CD133-positive stem cells and prognostic value of survivin in colorectal cancer.
    Kim ST; Sohn I; DO IG; Jang J; Kim SH; Jung IH; Park JO; Park YS; Talasaz A; Lee J; Kim HC
    Cancer Genomics Proteomics; 2014; 11(5):259-66. PubMed ID: 25331798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression and elevated plasma level of tumor-associated antigen 90K/Mac-2 binding protein in colorectal carcinoma.
    Wu CC; Huang YS; Lee LY; Liang Y; Tang RP; Chang YS; Hsieh LL; Yu JS
    Proteomics Clin Appl; 2008 Dec; 2(12):1586-95. PubMed ID: 21136809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.